semaglutide weight loss medicine Demand Rising for 'Bootlegged' Weight-Loss Drug Weight-loss drug tied to lower

For semaglutide, while the core patent (protecting the molecule itself) expires in 2026, Novo Nordisk has likely filed secondary patents on aspects like formulations, dosage regimens, or delivery mechanismspotentially extending protection into the 2030s

A further consideration in HPLC analysis is the size of the peptide, since choosing the correct particle pore size is important for ensuring interaction with the bonded phase and optimising peak shape

Diaphragmatic endometriosis: diagnosis, surgical management, and long-term results of treatment

Rectal Cancer Known as colorectal cancer, bowel cancer, or colon cancer, rectal cancer is the second most common cancer in the large intestine